A61P 13 - Drugs for disorders of the urinary system

Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
01/2012
01/03/2012	CA2488565C Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom
01/03/2012	CA2457719C Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect
01/03/2012	CA2455972C N6-benzyl and phenyl substituted adenines and their use as cosmetics, pharmaceutical preparations and plant growth regulators
01/03/2012	CA2395684C Sulfonamides and derivatives thereof that modulate the activity of endothelin
01/03/2012	CA2264562C Sustained peptide-release formulation
12/2011
12/29/2011	WO2011163085A2 Method and compositions use for endothelin-1 related kidney diseases
12/29/2011	WO2011162409A1 Compounds having trpv1 antagonistic activity and uses thereof
12/29/2011	WO2011162390A1 Sustained-release therapeutic agent for hypertension and renal dysfunction
12/29/2011	WO2011162267A1 Novel thiophenecarboxamide derivatives and use thereof as medicine
12/29/2011	WO2011160184A1 Method of treatment
12/29/2011	US20110319499 Methods for the Detection of Advanced Glycation Endproducts and Markers for Disease
12/29/2011	US20110319490 Methods and compositions for the treatment of irritable bowel syndrome
12/29/2011	US20110319476 Treatment of glial cell derived neurotrophic factor (gdnf) related diseases by inhibition of natural antisense transcript to gdnf
12/29/2011	US20110319465 Estrogen receptor modulators and uses thereof
12/29/2011	US20110319464 Methods for treating benign prostatic hyperplasia
12/29/2011	US20110319446 Bicyclo[2.2.1]hept-7-ylamine derivatives and their uses
12/29/2011	US20110319442 Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration
12/29/2011	US20110319440 Process for Preparing Spirocyclic Cyclohexane Compounds, Compositions Containing Such Compounds and Method of Using Such Compounds
12/29/2011	US20110319438 Novel sulfonamides as l-cpt1 inhibitors
12/29/2011	US20110319433 Fused heteroaryl pyridyl and phenyl benzenesuflonamides as ccr2 modulators for the treatment of inflammation
12/29/2011	US20110319431 Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors
12/29/2011	US20110319423 Novel dopamine d3 receptor ligands and preparation and medical uses of the same
12/29/2011	US20110319408 Methods of Treating Fibrosis, Cancer and Vascular Injuries
12/29/2011	US20110319401 Five crystal forms, methods of preparation, pharmaceutical compositions and applications of xlf-iii-43
12/29/2011	US20110319390 6-Aminoisoquinoline Compounds
12/29/2011	US20110319385 Quinoxaline compound
12/29/2011	US20110319348 Brassinosteroids in treating prostatic hyperplasia and androgenic alopecia
12/29/2011	US20110319333 Method and compositions for the treatment and detection of endothelin-1 related kidney diseases
12/29/2011	US20110319323 Pharmaceutical composition and method of use to improve organ function
12/29/2011	US20110319321 Mammalian colostrum derived nanopeptides for broadspectrum viral and recurrent infections with a method of isolation thereof
12/29/2011	US20110319317 Treatment of sirtuin 1 (sirt1) related diseases by inhibition of natural antisense transcript to sirt1
12/29/2011	US20110318425 TREATMENT OF INTERSTITIAL CYSTITIS USING (6aR, 10aR)- DELTA-8-TETRAHDRAOCANNABINOL-11-OIC ACIDS
12/29/2011	US20110318362 Novel card proteins involved in cell death regulation
12/29/2011	US20110318340 Deglycosylated antibodies
12/29/2011	CA2835151A1 Method of treatment
12/29/2011	CA2803163A1 Sustained-release therapeutic agent for hypertension and renal dysfunction
12/28/2011	EP2399917A1 Novel compounds comprising a 3-(5-alkoxypyrimidin-2-yl) pyrimidin-4(3h)-one structure and drugs that comprise same
12/28/2011	EP2399910A1 Novel triazine derivative and pharmaceutical composition containing same
12/28/2011	EP2399903A1 Ccr9 inhibitors and methods of use thereof
12/28/2011	EP2178858B1 Novel heterocyclic compounds as mglu5 antagonists
12/28/2011	CN1930135B 作为P2X<sub>3</sub>和P2X<sub>2/3</sub>拮抗剂的二氨基嘧啶 As P2X <sub> 3 </ sub> and P2X <sub> 2/3 </ sub> antagonists diaminopyrimidines
12/28/2011	CN1518444B 取代的6-二甲基氨基甲基-1-苯基环己烷化合物在制备治疗尿失禁的药物中的用途 Substituted 6-dimethylaminomethyl-1-phenyl-cyclohexane compound in the manufacture of a medicament for the treatment of urinary incontinence use
12/28/2011	CN102300568A Hif-1蛋白积聚的抑制剂 Hif-1 protein accumulation inhibitor
12/28/2011	CN102296016A 一种含生命激活素的保健养生酒及其制备方法 Containing activin life of health care liquor and its preparation method
12/28/2011	CN102295643A 2-(吡啶-2-基氨基)-吡啶并[2,3-d]嘧啶-7-酮 2- (pyridin-2-ylamino) - pyrido [2,3-d] pyrimidin-7-one
12/28/2011	CN102293954A 一种治疗尿路结石的中药组合物 A treatment of urinary tract stones herbal composition
12/28/2011	CN102293930A 一种治疗前列腺增生的中药 A traditional Chinese medicine treatment of benign prostatic hyperplasia
12/28/2011	CN102293897A 六味地黄丸的制备方法 Preparation of Liuweidihuangwan
12/28/2011	CN102293873A 八正合剂的制备方法 Mixture preparation Bazheng
12/28/2011	CN102293859A 一种治疗前列腺增生肥大的药物 An prostatic hypertrophy medications
12/28/2011	CN102293857A 地黄车前方中有效组分群治疗慢性肾小球肾炎发明 To yellow car in front of the effective components group therapy of chronic glomerulonephritis invention
12/28/2011	CN102293855A 治疗脾肾两虚型糖尿病肾病的中药组合物及其制备方法与应用 Treatment of diabetic nephropathy spleen deficiency type of traditional Chinese medicine composition and its preparation method and application
12/28/2011	CN102293812A 石淋通颗粒的制备方法 Preparation Shilin particles
12/28/2011	CN102293808A 一种玛咖冻干粉针剂及其制备方法 Maca one kind of freeze-dried powder and its preparation method
12/28/2011	CN102293798A 爵床药材的质量控制方法 Quality control of medicines Acanthaceae
12/28/2011	CN102293763A 肾病和心脏病的治疗药物及其用途 Kidney disease and heart disease drugs and their uses
12/28/2011	CN102085299B 治疗前列腺炎的中成药物及其制备方法 Chinese medicine treatment of prostatitis and its preparation method
12/28/2011	CN101849968B 一种强肾胶囊药物及其制造方法 One kind of drug Qiangshen capsule and its manufacturing method
12/28/2011	CN101664499B 仙藿补肾合剂 Sin kidney beans Mixture
12/28/2011	CN101623438B 槐杞黄颗粒复方制剂在治疗肾病中的应用 Huaiqihuang granular compound preparation used in the treatment of kidney disease
12/28/2011	CN101480449B 枸杞在预防尿结石中的应用 Wolfberry application in the prevention of urinary stones
12/28/2011	CN101439122B 一种含熟地黄提取物的中药颗粒及其制备方法 Chinese medicine granules and preparation method extracts containing Rehmannia
12/28/2011	CN101007000B 异黄酮化合物的制药用途以及含有它们的组合物 Isoflavone compounds and pharmaceutical use of the compositions containing them
12/27/2011	US8084645 4-phenylamino-benzaldoxime derivatives and uses thereof as mitogen-activated protein kinase kinase (MEK) inhibitors
12/27/2011	US8084441 Cystitis treatment with high dose chondroitin sulfate
12/27/2011	US8084049 Complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives
12/22/2011	WO2011159824A1 Composition and method for treating overactive bladder
12/22/2011	WO2011158933A1 Agent for treating renal fibrosis
12/22/2011	WO2011158931A1 Useful salts of indazole derivative
12/22/2011	WO2011158904A1 Therapeutic agent for inflammatory diseases containing adenosine n1-oxide as active ingredient
12/22/2011	WO2011158880A1 Crystal of amide compound
12/22/2011	WO2011093825A3 Effervescent dosage forms comprising cephalosporin antibiotic
12/22/2011	WO2011093824A3 Effervescent formulations comprising cefaclor
12/22/2011	US20110313041 Food supplements on the basis of pantothenic acid
12/22/2011	US20110313036 CRYSTALLINE FORM OF y-AMINOBUTYRIC ACID ANALOG
12/22/2011	US20110313004 Deuterated pyridinones
12/22/2011	US20110313000 Ccr9 inhibitors and methods of use thereof
12/22/2011	US20110312986 Composition and Method for Treating Overactive Bladder
12/22/2011	US20110312979 Fused pyrrole derivatives as pi3k inhibitors
12/22/2011	US20110312962 Novel 2-morpholino-3-amido-pyridine derivatives and their medical use
12/22/2011	US20110312960 Pyrazine derivatives and use as pi3k inhibitors
12/22/2011	US20110312954 Mineralocorticoid receptor antagonist and methods of use
12/22/2011	US20110312944 Heterocyclic Compounds Which Modulate The CB2 Receptor
12/22/2011	US20110312930 Aryl compounds with aminoalkyl substituents and their use
12/22/2011	US20110312922 EDTA Resistant S100A12 Complexes (ERAC)
12/22/2011	US20110312878 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
12/22/2011	US20110312872 Norrin in the treatment of diseases associated with an increased tgf-beta activity
12/22/2011	US20110311652 Novel Saponin Compounds, Methods of Preparation Thereof, Use Thereof and Pharmaceutical Compositions
12/22/2011	US20110311620 Novel modified release dosage forms of xanthine oxidoreductase inhibitor or xanthine oxidase inhibitors
12/22/2011	US20110311531 Immunotherapy of autoimmune disorders using antibodies which target b-cells
12/22/2011	US20110311530 Truncated baff receptors
12/22/2011	US20110311495 Isolated populations of renal stem cells and methods of isolating and using same
12/22/2011	US20110311494 Methods of reprogramming renal cells
12/22/2011	US20110311451 Synthesis of polymer conjugates of indolocarbazole compounds
12/22/2011	CA2802483A1 Crystal of amide compound
12/22/2011	CA2802414A1 Agent for treating renal fibrosis
12/21/2011	EP2397494A1 Human antibodies that bind human TNFalpha
12/21/2011	EP2397134A1 A pharmaceutical composition for treating diabetic nephropathy and the preparation method and use thereof
12/21/2011	EP1880995B1 Method for producing indole derivative having piperidine ring
12/21/2011	EP1534290B1 Novel inhibitors of kinases

1 ... 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 ... 562